Childhood B Acute Lymphoblastic Leukemia

hematologic malignancy

Identifier: CI-CAN-00002201
Entity page: /cancer/childhood-b-acute-lymphoblastic-leukemia ↗
Edges: 78

Neighbours: 42 drugs10 trials
Drawn: 52 of 52 neighbours (cap 60); table lists every fetched edge

Accepted: cancer:<slug>, gene:<symbol>, variant:<slug>, drug:<slug>, trial:<NCT id>, or a bare CI id. Find slugs with search.

Most connectedLung Non-Small Cell Carcinoma 3,147 Malignant Colorectal Neoplasm 1,866 ABL1 298 EGFR 276 Imatinib 450 Dasatinib 321

Neighbourhood

Radial view

Focus at the centre; neighbours grouped by entity type. Click a node to re-centre the graph on it; ↗ opens the entity page. Hover a spoke for relationship, evidence level, cancer context and source.

Edges

Every edge, grouped by relationship

Source-native edges first (aggregated per neighbour, direction, evidence level and source), then derived registry links. Up to 15 per relationship (10 trials); “show all” raises one group to 200.

Relationship	Neighbour	Direction	Evidence level	Cancer context	Support	Claim	Source	Expand
Childhood B Acute Lymphoblastic Leukemia investigated in trials for …INVESTIGATED_IN_TRIALSderived42 of 42show fewer
→ investigated in trials for	Methotrexatesmall molecule 14 trials (1 active) · roll-up of the cancer and its descendants	—	—	Childhood B Acute Lymphoblastic Leukemia	14	Observed	clinicaltrials	graph →
→ investigated in trials for	Cyclophosphamide

Childhood B Acute Lymphoblastic Leukemia studied in …STUDIED_INderived10 of 36show all (up to 200)
→ studied in	NCT07770698Phase 1/Phase 2 · not yet recruiting A Study of Sonrotoclax (BGB-11417) in Children With Relapsed or Refractory Acute Myeloid Leukemia and B-cell Acute Lymphoblastic Leukemia · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT01190930Phase 3 · completed Risk-Adapted Chemotherapy in Treating Younger Patients With Newly Diagnosed Standard-Risk Acute Lymphoblastic Leukemia or Localized B-Lineage Lymphoblastic Lymphoma · condition mapped ONTOLOGY_EXACT · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT07422337recruiting A Multi-site Study to Evaluate the Persistence of Protective Immunity to Routine Childhood Vaccinations in Participants With B-ALL/Ly Who Have Received Blinatumomab · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06287528Phase 1 · recruiting A Study of 19-28z/IL-18 in People With Acute Lymphoblastic Leukemia (ALL) · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT04722848Phase 3 · active not recruiting Sequential Treatment With Ponatinib and Blinatumomab vs Chemotherapy and Imatinib in Newly Diagnosed Adult Ph+ ALL · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT04475731Phase 2 · active not recruiting Ponatinib in Adult Ph+ ALL Patients With MRD Positivity or Hematological Relapse · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT00381680Phase 3 · completed Low-Dose or High-Dose Vincristine and Combination Chemotherapy in Treating Young Patients With Relapsed B-Cell Acute Lymphoblastic Leukemia · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia	1	Observed	clinicaltrials	graph →
→ studied in	NCT06220487Phase 2 · recruiting A Single-arm, Open-label Study of Olverembatinib, CD3/CD19 Bispecific T-cell Engager, and Chidamide in Patients With Newly Diagnosed Ph+ALL · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT06175702not yet recruiting Treatment Protocol for Newky Diagnosed Adult Ph Positive ALL · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →
→ studied in	NCT05931757Phase 2 · not yet recruiting A Study of Olverembatinib Combined With Blinatumomab in the Treatment of Ph+ ALL · condition mapped ALIAS · 36 trials mapped (9 active)	—	—	Childhood B Acute Lymphoblastic Leukemia with t(9;22)(q34.1;q11.2); BCR-ABL1	1	Observed	clinicaltrials	graph →

Radial view

Every edge, grouped by relationship

Strongest chains